Australia
# |
Name |
Operating Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
12.55%
|
June 30, 2024 | USD 169.95 | -0.56% |
|
Australia |
|
2 |
-118.32%
|
June 30, 2024 | USD 2.04 | -5.56% |
|
Australia |
|
3 |
-487.69%
|
June 30, 2024 | USD 4.80 | 5.03% |
|
Australia |
|
4 |
-2,293.26%
|
June 30, 2024 | USD 2.09 | 0.97% |
|
Australia |
|
5 |
-250,341.67%
|
June 30, 2024 | USD 1.67 | 2.45% |
|
Australia |
The Vaccines company in Australia with the highest Operating Income Margin is CSL Limited (ASX: CSL.AX) at 12.55%.
The Vaccines company in Australia with the lowest Operating Income Margin is Incannex Healthcare Limited (NasdaqGM: IXHL) at -250,341.67%.
The top 10 Vaccines companies in Australia by Operating Income Margin are CSL Limited, Immuron Limited, Alterity Therapeutics Limited, Immutep Limited and Incannex Healthcare Limited.
The bottom 10 Vaccines companies in Australia by Operating Income Margin are Incannex Healthcare Limited, Immutep Limited, Alterity Therapeutics Limited, Immuron Limited and CSL Limited.